Relates to the labeling of mifepristone, misoprostol, and their generic alternatives

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 8 Sponsors

Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

Chamber: House
Introduced: Jan 15, 2025
Last action: Jan 22, 2025 — SUBSTITUTED BY S36A
Session: 2025-2026
Momentum: 54 · Moderate

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Amended — base rate 13%, measured from NY's completed sessions
Momentum +1 54/100 from the pace of recorded action
Time since last action -22 626 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.